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compartment enhance diagnostic utility of
sacroiliac joint MRI in axial spondyloarthritis?
Ulrich Weber1,2,3*, Walter P. Maksymowych4, Stanley M. Chan5, Kaspar Rufibach6, Susanne J. Pedersen7,
Zheng Zhao8, Veronika Zubler9, Mikkel Østergaard7 and Robert GW Lambert10Abstract
Introduction: Inflammation of the sacroiliac joints (SIJ) is a fundamental clinical feature of axial spondyloarthritis
(SpA). The anatomy of the irregularly shaped SIJ is complex with an antero-inferior cartilaginous compartment
containing central hyaline and peripheral fibrocartilage, and a dorso-superior ligamentous compartment. Several
scoring modules to systematically assess SIJ magnetic resonance imaging (MRI) in SpA have been developed.
Nearly all of them are based on the cartilaginous joint compartment alone. However, there are only limited data
about the frequency of inflammatory lesions in the ligamentous compartment and their potential diagnostic utility
in axial SpA. We therefore aimed to evaluate the ligamentous compartment on sacroiliac joint MRI for lesion
distribution and potential incremental value towards diagnosis of SpA over and above the traditional assessment
of the cartilaginous compartment alone.
Methods: Two independent cohorts of 69 and 88 consecutive back pain patients ≤50 years were referred for
suspected SpA (cohort A) or acute anterior uveitis plus back pain (cohort B). Patients were classified according to
rheumatologist expert opinion based on clinical, radiographic and laboratory examination as having nonradiographic
axial SpA (nr-axSpA; n = 51), ankylosing spondylitis (n = 34), or nonspecific back pain (NSBP; n = 72). Five blinded
readers assessed SIJ MRI globally for presence/absence of SpA. Bone marrow edema (BME) and fat metaplasia were
recorded in the cartilaginous and ligamentous compartment. The incremental value of evaluating the ligamentous
additionally to the cartilaginous compartment alone for diagnosis of SpA was graded qualitatively. We determined the
lesion distribution between the two compartments, and the impact of the ligamentous compartment evaluation on
diagnostic utility.
Results: MRI bone marrow lesions solely in the ligamentous compartment in the absence of lesions in the
cartilaginous compartment were reported in just 0–2.0/0–4.0 % (BME/fat metaplasia) of all subjects. Additional
assessment of the ligamentous compartment was regarded as essential for diagnosis in 0 and 0.6 %, and as
contributory in 28.0 and 7.7 % of nr-axSpA patients in cohorts A and B, respectively. Concomitant BME in both
compartments was evident in 11.6–42.0 % of nr-axSpA and 2.1–2.4 % of NSBP patients.
Conclusion: Assessing the ligamentous compartment on SIJ MRI provided no incremental value for diagnosis of axial
SpA. However, concomitant BME in both compartments may help discriminate nr-axSpA from NSBP.* Correspondence: ulrich.weber02@bluewin.ch
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Inflammation of the sacroiliac joints (SIJ) is a fundamental
clinical feature of axial spondyloarthritis (SpA), and sacroi-
liitis on magnetic resonance imaging (MRI) represents a
major criterion in the Assessment of SpondyloArthritis
International Society (ASAS) classification for axial SpA
[1]. The anatomy of the irregularly curved SIJ is complex
with an antero-inferior cartilaginous compartment, which
contains central hyaline and peripheral fibrocartilage, and
a dorso-superior ligamentous compartment [2, 3]. Small
case series and anecdotal reports in patients with early
spondyloarthritis suggest that inflammation starts in the
subchondral bone marrow of the cartilaginous SIJ com-
partment [4–12].
Several scoring modules to systematically assess SIJ
MRI in SpA have been developed. Nearly all of them are
based on the cartilaginous joint compartment alone
[13–19], and magnetic resonance images are acquired in a
tilted semi-coronal plane running parallel to the posterior
aspect of the sacrum. When scrolling from anterior to
posterior through semi-coronal magnetic resonance im-
ages of the SIJ, the cartilaginous compartment is displayed
on the first 5–6 MRI slices. The subsequent 1–2 slices
have been termed “transitional” slices as they show
both cartilaginous and ligamentous portions. The mostFig. 1 MRI studies of a 22-year-old man, human leucocyte antigen B27-positi
modified New York criteria were not met, and C-reactive protein was 7 mg/l
inversion recovery (STIR) and corresponding T1 spin echo (T1SE) sequences, r
compartment (solid white arrow on T1SE), the right panel from the ligamento
transitional slice containing parts of both the cartilaginous and ligamentous c
pattern of the space between the ilium and the sacrum in the ligamentous co
have low MRI signal intensity surrounded by fat tissue which is bright on T1SE.
low signal ligaments and fat tissue as the fat signal is suppressed on STIR, and
patient with nonradiographic axial spondyloarthritis, bone marrow edema (cur
right sacroiliac joint extends from the cartilaginous into the ligamentous compposterior 3–4 slices depict the ligamentous compartment
(Fig. 1). An assessment module of the SIJ developed by a
Danish working group also scores inflammation in the
bone marrow of the ligamentous SIJ compartment [20–22].
Magnetic resonance images for the Danish method are
obtained not only in a semi-coronal but also in a semi-
axial plane perpendicular to the long axis of the SIJ, which
allows simultaneous assessment of the bone marrow in
the ligamentous and cartilaginous compartments on the
same image. However, there are only limited data about
the frequency of inflammatory lesions in the ligamentous
compartment and their incremental value towards diag-
nostic utility in axial SpA over and above the assessment
of the cartilaginous compartment alone.
The goals of this study on SIJ MRI in two axial SpA
inception cohorts were: (1) to systematically evaluate the
frequency of bone marrow edema (BME) and fat meta-
plasia in the bone marrow of both the cartilaginous and
ligamentous SIJ compartment by semi-coronal magnetic
resonance images in SpA patients and controls; and (2)
to assess the incremental value of the additional evalu-
ation of the ligamentous compartment on diagnostic
utility over and above the traditional assessment of the
cartilaginous compartment alone in nonradiographic
axial SpA (nr-axSpA) patients.ve, with a 4-month history of inflammatory back pain. The radiographic
(reference limit ≤5 mg/l). The upper and lower rows show short tau
espectively. The left panel represents an MRI slice from the cartilaginous
us compartment (broken white arrow on T1SE), and the central panel is a
ompartment (solid and broken white arrows on T1SE). The black and white
mpartment has its origin on the T1SE images in sacroiliac ligaments which
On the STIR sequence, the ligamentous compartment is comprised of
the bright signal relates to fluid in the lumen of blood vessels. In this
ved white and black arrows on STIR) predominantly in the iliac part of the
artment
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Subjects
The demographical and clinical characteristics of the
study sample have been described elsewhere [23]. Two
different approaches were used to recruit two inception
cohorts of consecutive back pain patients aged ≤50 years
newly referred to two university outpatient departments.
Back pain patients referred by rheumatologists and pri-
mary care physicians for further evaluation of clinically
suspected SpA were enrolled in cohort A (n = 69;
University of Zurich). The same university clinic con-
comitantly recruited 20 age-matched healthy controls
from hospital staff, defined by the Nordic questionnaire
[24] and by absence of clinical features indicative for
SpA. Patients of cohort B (n = 88; University of Alberta)
presented with acute anterior uveitis (AAU) to a univer-
sity ophthalmology department and were referred to
rheumatology of the same university hospital for assess-
ment of SpA if they indicated past or present back pain
for ≥3 months on a structured questionnaire. Cohort A
and B, being based on two different recruitment strat-
egies, reflect more comprehensively the spectrum of
SpA phenotypes seen in daily routine than would be by
each cohort alone.
There is no standardized or generally accepted gold
standard for imaging studies in axial SpA [25]. MRI
cannot be used simultaneously for classification and for
evaluating its diagnostic utility for reasons of conceptual
circularity [26]. Rheumatologist expert opinion, which was
consistently used as gold standard in three SpA classifica-
tion criteria sets (Amor [27], European Spondylarthro-
pathy Study Group (ESSG) [28], ASAS [1]), served as gold
standard for diagnosis of axial SpA. In both inception co-
horts, clinician expert opinion by one local rheumatologist
(UW for cohort A and WPM for cohort B) based on clin-
ical examination inclusive of standardized evaluation of
inflammatory back pain according to Calin criteria [29]
and of structured questionnaires on SpA-related fea-
tures (modified Outcome in Ankylosing Spondylitis
International Study (OASIS) protocol [30] for cohort A
and Spondyloarthritis Research Consortium of Canada
(SPARCC) protocol [31] for cohort B), pelvic radiographs
and laboratory values (human leucocyte antigen B27
(HLA-B27), C-reactive protein (CRP)) served to classify
the back pain patients as having nr-axSpA (n = 20 and 31
for cohorts A and B, respectively), ankylosing spondylitis
(AS; n = 10 and 24 for cohorts A and B, respectively) and
nonspecific back pain (NSBP; n = 39 and 33 for cohorts A
and B, respectively). Two readers at each site independ-
ently categorized pelvic radiographs according to the
modified New York criteria [32], and discrepancies were
solved by consensus. Current or previous treatment with
biologics was an exclusion criterion in both cohorts. The
study protocols were approved by the local Ethics ReviewBoards (Ethics Committee of the University of Alberta,
Edmonton, Canada; Kantonale Ethikkommission Zurich,
Zurich, Switzerland) and written informed consent was
obtained from the study participants.
Evaluation of magnetic resonance images
The technical parameters for short tau inversion recov-
ery (STIR) and T1 spin echo (T1SE) sequences of semi-
coronal MRI SIJ scans have been reported previously
[17]. The MRI scans (1.5 T Avanto, Siemens Medical
Solutions, Erlangen, Germany, for cohorts A and B)
were read and scored independently by five blinded
readers (one radiologist: VZ; four rheumatologists: SJP,
UW, WPM and ZZ). The images of each cohort were
evaluated separately in random order on electronic work
stations, and MRI scores were entered into a customized
online data entry module.
The evaluation of the cartilaginous compartment on SIJ
MRI followed a standardized module [16, 17, 23] com-
prising two sections. The first section represented a global
assessment indicating presence/absence of SpA according
to both structural and active MRI features by viewing
T1SE and STIR sequences simultaneously. The confidence
in the global assessment was expressed by a numeric rat-
ing scale (NRS) score ranging from 0 (definitely nonSpA)
to 10 (definitely SpA). The second section contained a
detailed assessment recording BME and fat metaplasia ac-
cording to standardized lesion definitions and a reference
SIJ MRI set developed by consensus amongst study inves-
tigators [33]. BME and fat metaplasia in the bone marrow
of the cartilaginous joint compartment were recorded as
present/absent in each quadrant (upper and lower ilium,
upper and lower sacrum) of each SIJ, based on evaluation
of each MRI slice [17].
The assessment of the ligamentous compartment on SIJ
MRI also comprised a global and a lesion-based section.
Readers reported in the global section whether the add-
itional evaluation of the ligamentous joint compartment
provided an incremental value (expressed by the three cat-
egories “essential”, “contributory” or “noncontributory”)
over and above the global assessment based on the cartil-
aginous joint compartment alone. Readers also recorded
whether the additional evaluation of the ligamentous joint
compartment changed diagnosis (from nonSpA to SpA or
vice versa) or altered the confidence in a diagnosis of SpA
based on MRI assessment of the cartilaginous compart-
ment alone. The complex anatomy of the ligamentous
joint compartment precluded an evaluation per joint
quadrants. BME and fat metaplasia were recorded as
present/absent if observed in bone marrow on any slice of
the ligamentous compartment. Erosions were not scored
in the ligamentous compartment because they cannot be
discriminated reliably from physiological insertions of
SIJ ligaments.
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Data description
Differences in demographic and clinical characteristics
between cohorts A and B were assessed by Fisher’s exact
test for nominal and Wilcoxon test for continuous vari-
ables. We calculated the mean percentage of patients
and controls over five readers showing ≥1 BME or ≥1 fat
metaplasia lesion (dichotomously indicating 'presence' or
'absence' of lesions) in the cartilaginous and ligamentous
SIJ compartment, respectively.
Interobserver agreement on MRI lesions in both SIJ
compartments
Interobserver reliability of MRI lesions was evaluated in
both joint compartments because it might be expected
that detection of lesions in the ligamentous compart-
ment would be less reliable due to its more complex
anatomy. Percent agreement (positive and negative con-
cordance) among the 10 possible reader pairs for each
group of study subjects, and weighted Cohen’s kappa
values for five readers jointly per cohort [34] were used
to calculate the reproducibility of BME and fat meta-
plasia among the five readers for the cartilaginous and
ligamentous SIJ compartments. Kappa values were not
calculable for all categories of study subjects due to
small sample sizes of n = 10–39 for nr-axSpA, AS, NSBP
and healthy controls (HC) [35]. The inter-reader agree-
ment was defined as slight, fair, moderate, substantial and
almost perfect by values of the weighted Cohen’s kappa
κ < 0.2, κ = 0.2– < 0.4, κ = 0.4– < 0.6, κ = 0.6– < 0.8,
and κ = 0.8–1, respectively [36]. For kappa values, we
provide bootstrap confidence intervals based on 1000
bootstrap replications and computed at a confidence
level of 95 %.
MRI lesions in the cartilaginous versus ligamentous joint
compartment
We calculated the mean percentage of patients and con-
trols over five readers who showed ≥1 MRI lesion both
in the cartilaginous and ligamentous compartment, and
in only one or in none of the two joint compartments,
separately for BME and fat infiltration. The constellation
of lesions observed solely in the ligamentous compart-
ment without corresponding lesions in the cartilaginous
compartment was further analyzed regarding agreement
among the five readers.
Impact of the ligamentous joint compartment on
classification
We calculated the mean percentage of patients and con-
trols over five readers where the additional evaluation of
the ligamentous compartment was regarded as essential,
contributory or noncontributory for diagnosis of SpA ver-
sus nonSpA beyond the assessment of the cartilaginouscompartment alone. We further analyzed whether the add-
itional evaluation of the ligamentous compartment led to a
switch in diagnosis (assessment of the cartilaginous com-
partment alone indicating nonSpA that changes to SpA by
additional evaluation of the ligamentous compartment).
We also assessed how often confidence in diagnosis of
SpA increased from 5–7 to 8–10 following additional
evaluation of the ligamentous compartment, and we
expressed this as mean percentage of patients and controls
over five readers.
We used R Core Team 2014, version 3.1.0, Vienna,
Austria, for statistical analysis [37].
Results
Data description
Table 1 displays the characteristics of the two SpA incep-
tion cohorts representing a wide spectrum of SpA pheno-
types. The two strategies to recruit patients with early SpA
resulted in substantial demographical and clinical differ-
ences between the two cohorts, with cohort B having lon-
ger symptom duration and less disease activity. This
disparity with regards to symptom duration, age of study
participants and disease activity justified analysis of the two
cohorts separately.
MRI bone marrow lesions were less frequent in the
ligamentous than cartilaginous compartment, consist-
ently across both cohorts, all study groups, and for both
lesion types. Among nr-axSpA patients, BME in the
ligamentous/cartilaginous compartment occurred in
42.0/83.0 % and 11.6/45.2 % for cohorts A and B, re-
spectively, and fat metaplasia in 21.0/47.0 % and 25.2/
43.9 %, respectively (Table 1). The same disparity was
observed in AS patients, but with higher overall lesion
frequencies. The disparity in MRI lesion frequency be-
tween the cartilaginous and the ligamentous compart-
ment was particularly pronounced for BME in NSBP
patients. In cohorts A and B, 27.7 and 27.9 % of NSBP
patients had BME in the cartilaginous versus only
3.6 and 2.4 % in the ligamentous compartment,
respectively.
In cohorts A and B, BME in the ligamentous compart-
ment was recorded in 80.0 and 38.3 % of AS patients, re-
spectively, compared to 42.0 and 11.6 % of nr-axSpA
patients. Similarly, fat metaplasia in the ligamentous com-
partment was observed more often in AS (46.0 and 42.5 %
for cohorts A and B, respectively) than in nr-ax-SpA (21.0
and 25.2 %, respectively) patients. However, a comparable
difference in lesion frequency between AS and nr-axSpA
groups was also recorded for the cartilaginous com-
partment. BME in the cartilaginous compartment was
reported in 88.0 and 74.2 % of AS and 83.0 and 45.2 % of
nr-axSpA patients in cohorts A and B, and fat metaplasia
in 66.0 and 79.2 % of AS and 47.0 and 43.9 % of nr-axSpA
patients.
Table 1 Demographical and clinical characteristics of two spondyloarthritis inception cohorts, and percentage of subjects with bone
marrow edema or fat metaplasia in the cartilaginous and ligamentous compartments of the sacroiliac joints (mean percentage over
five readers)
Cohort A (n = 89) B (n = 88)
Recruitment mode Suspected axial SpA by practising rheumatologists or PCP AAU plus past or present back pain
Group nr-axSpA AS NSBP HC nr-axSpA AS NSBP
Number of subjects 20 10 39 20 31 24 33
Male:female (% male) 11:9 (55.0) 8:2 (80.0) 11:28 (28.2) 7:13 (35.0) 17:14 (54.8) 11:13 (45.8) 17:16 (51.5)
Age (years) 32.2 (12.3) 30.0 (9.5)* 32.7 (11.5) 30.6 (6.5) 36.2 (12.1) 41.5 (7.1)* 33.6 (15.7)
Symptom duration (years) 1.3 (1.8)* 3.9 (1.8)* NA NA 10.0 (14.0)* 12.5 (13.5)* NA
HLA B27 positive (%) 12 (60.0) 9 (90.0) ND ND 24 (80.0)b 21 (87.5) 10 (55.6)b
BASDAI (NRS) 4.4 (3.1)a 5.4 (1.5)a NA NA 3.5 (4.4) 2.0 (3.4)b NA
BASFI (NRS) 1.8 (3.9)*a 2.7 (1.5)a NA NA 0.8 (2.3)* 0.6 (2.8)b NA
CRP (mg/l) 4.0 (4.5)a 5.0 (8.0)a ND ND 2.7 (5.2) 8.0 (8.7)b 0.9 (0.9)b
BME cart 83.0 88.0 27.7 34.0 45.2 74.2 27.9
BME lig 42.0 80.0 3.6 6.0 11.6 38.3 2.4
Fat cart 47.0 66.0 29.2 18.0 43.9 79.2 22.4
Fat lig 21.0 46.0 17.9 12.0 25.2 42.5 9.1
Values for patient characteristics are the median (interquartile range; expressed as difference between first and third quartile) unless otherwise stated
*P ≤ 0.05 (Fisher’s exact test) between cohorts A and B
aCohort A: CRP values are based on 18, and BASDAI/BASFI values on 19 patients with nr-axSpA, respectively; BASDAI/BASFI and CRP values are based on 9
patients with AS
bCohort B: HLA B27 values are based on 30 patients with nr-axSpA; BASDAI/BASFI and CRP values are based on 22 patients with AS; in NSBP patients, HLA B27
and CRP values are based on 18 subjects; the prevalence of HLA B27 in patients with AAU in general is 50–60 % [41]
AAU Acute anterior uveitis, AS Ankylosing spondylitis, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional
Index, BME Bone marrow edema, Cart Cartilaginous compartment of the sacroiliac joint, CRP C-reactive protein (reference range ≤5 mg/l), Fat Fat metaplasia,
HC Healthy control, HLA B27 Human leucocyte antigen B27, Lig Ligamentous compartment of the sacroiliac joint, NA Not applicable, ND Not done, nr-axSpA Nonradiographic
axial spondyloarthritis, NRS Numeric rating scale, NSBP Nonspecific back pain, PCP Primary care physician
Weber et al. Arthritis Research & Therapy  (2015) 17:246 Page 5 of 9Interobserver agreement on MRI lesions in both joint
compartments
Agreement by percent concordance among 10 possible
reader pairs for BME and fat metaplasia showed no sys-
tematic discrepancies between the two joint compart-
ments across both cohorts (Table 2). In cohort A, Cohen’s
kappa over five readers jointly for BME was substantial
and comparable for the cartilaginous (kappa = 0.66) and
ligamentous (kappa = 0.68) compartment. In cohort B,
kappa for BME was substantial in the cartilaginous com-
partment (0.64), but fair for the ligamentous compartment
(0.37). In cohorts A and B, Cohen’s kappa for fat meta-
plasia was moderate in the cartilaginous compartment
(0.40/0.51 in cohorts A and B, respectively) and fair for
the ligamentous compartment (0.36/0.39 in cohorts A and
B, respectively).
MRI lesions in the cartilaginous versus ligamentous joint
compartment
MRI lesions occurring concomitantly in the cartilaginous
and ligamentous SIJ compartment were recorded more
frequently in AS than in nr-axSpA patients, both for
BME and fat metaplasia and across both cohorts A and
B (BME: 80.0 and 37.5 % in AS, and 42.0 and 11.6 % in
nr-axSpA; fat metaplasia: 42.0 and 41.7 % in AS, and21.0 and 25.2 % in nr-axSpA, respectively) (Table 3). By
contrast, concomitant BME in both joint compartments
was consistently very rare in controls of both cohorts A
and B (NSBP patients 2.1 and 2.4 %; healthy controls in
cohort A 4.0 %). Thus, the constellation of concomitant
BME lesions in both the cartilaginous and ligamentous
compartment showed more frequently in nr-axSpA (42.0
and 11.6 %) than in NSBP patients (2.1 and 2.4 %) in co-
horts A and B. BME or fat metaplasia lesions solely in
the ligamentous compartment were virtually absent for
all groups of study subjects across both cohorts (0–2.0 %
for BME and 0–4.0 % for fat metaplasia, respectively),
and they were never recorded at the same site by more
than one out of five readers.
Impact of the ligamentous joint compartment on
diagnosis
The additional evaluation of the ligamentous compart-
ment for diagnosis of SpA versus nonSpA over and
above the assessment of the cartilaginous compartment
alone was regarded as essential by one single reader in
one nr-axSpA patient of cohort B enhancing the con-
fidence in a diagnosis of SpA from 7 to 10 on a NRS
ranging from 0–10 (Table 4). Otherwise none of the liga-
mentous joint assessments in any of the two cohorts
Table 2 Agreement as percent concordance among 10 possible reader pairs for each group of study subjects (kappa values for five
readers jointly per cohort)
Cohort A (n=89) B (n=88)
Group nr-axSpA AS NSBP HC nr-axSpA AS NSBP
Number of subjects 20 10 39 20 31 24 33
Percent concordance among 10 reader pairsa
Total (positive/negative)
BME cart 88.0 (77.0/11.0) 88.0 (82.0/6.0) 78.5 (16.9/61.5) 85.0 (26.5/58.5) 78.1 (34.2/43.9) 78.3 (63.3/15.0) 86.7 (20.6/66.1)
BME lig 78.0 (31.0/47.0) 92.0 (76.0/16.0) 93.8 (0.5/93.3) 89.0 (0.5/88.5) 87.7 (5.5/82.3) 61.7 (19.2/42.5) 97.0 (0.9/96.1)
Fat cart 69.0 (31.5/37.5) 64.0 (48.0/16.0) 74.9 (16.7/58.2) 74.0 (5.0/69.0) 76.8 (32.3/44.5) 70.8 (64.6/6.3) 76.4 (10.6/65.8)
Fat lig 77.0 (9.5/67.5) 64.0 (28.0/36.0) 82.1 (9.0/73.1) 86.0 (5.0/81.0) 77.4 (13.9/63.5) 60.8 (22.9/37.9) 89.1 (3.6/85.5)
Kappa value for five readers jointly (95 % CI)b
BME cart 0.66 (0.56–0.75) 0.64 (0.53–0.72)
BME lig 0.68 (0.55–-0.79) 0.37 (0.26–0.45)
Fat cart 0.40 (0.32–0.49) 0.51 (0.42–0.60)
Fat lig 0.36 (0.25–0.45) 0.39 (0.25–0.51)
aPercent concordance among 10 possible reader pairs (100 % = 10 concordant reader pairs); Total = positive and negative concordance for presence/absence of
BME or fat metaplasia in the cartilaginous and ligamentous compartment of the sacroiliac joints
bWeighted Cohen’s kappa values for all five readers jointly
AS Ankylosing spondylitis, BME Bone marrow edema, Cart Cartilaginous compartment of the sacroiliac joint, CI 95 % confidence interval, Fat Fat metaplasia,
HC Healthy control, Lig Ligamentous compartment of the sacroiliac joint, nr-axSpA Nonradiographic axial spondyloarthritis, NSBP Nonspecific back pain, R Reader,
RP Reader pair
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28.0 and 7.7 % of nr-axSpA patients in cohorts A and B,
respectively, was the evaluation of the ligamentous
compartment considered contributory to diagnosis. The
additional assessment of the ligamentous compartment
was regarded as noncontributory for diagnosis in 72.0
and 91.6 % of nr-axSpA patients in cohorts A and B.Table 3 Bone marrow edema and fat metaplasia in the
cartilaginous versus ligamentous sacroiliac joint compartment
(mean percentage of subjects over five readers)
Cohort A (n=89) B (n=88)
Group nr-axSpA AS NSBP HC nr-axSpA AS NSBP
Number of subjects 20 10 39 20 31 24 33
BME cart+/lig+ 42.0 80.0 2.1 4.0 11.6 37.5 2.4
BME cart+/lig– 41.0 8.0 25.6 30.0 33.5 36.7 25.5
BME cart–/lig+ 0 0 1.5a 2.0a 0 0.8a 0
BME cart–/lig– 17.0 12.0 70.8 64.0 54.8 25.0 72.1
Fat cart+/lig+ 21.0 42.0 17.4 12.0 25.2 41.7 8.5
Fat cart+/lig– 26.0 24.0 11.8 6.0 18.7 37.5 13.9
Fat cart–/lig+ 0 4.0b 0.5b 0 0 0.8b 0.6b
Fat cart–/lig– 53.0 30.0 70.3 82.0 56.1 20.0 77.0
aBME cart–/lig+: three NSBP patients and two HC by one single reader in
cohort A; one AS patient by one reader in cohort B
bFat cart–/lig+: two AS and one NSBP patient by three different readers in
cohort A; one AS and one NSBP patient by two different readers in cohort B
AS Ankylosing spondylitis, BME Bone marrow edema, Cart Cartilaginous
compartment of the sacroiliac joint, Fat Fat metaplasia, HC Healthy control,
Lig Ligamentous compartment of the sacroiliac joint, nr-axSpA Nonradiographic
axial spondyloarthritis, NSBP Nonspecific back painNone of the ligamentous joint assessments led to a
change in diagnosis.
Discussion
In two SpA inception cohorts reflecting routine practice
with broad variation of symptom duration and disease
activity, assessment of the ligamentous compartment on
SIJ MRI provided no incremental value for diagnosis of
axial SpA compared to the traditional evaluation of the
cartilaginous SIJ compartment alone. Redundancy of
MRI lesions in the ligamentous and cartilaginous com-
partment is the most likely explanation: nearly all SpA
and control subjects having BME and/or fat metaplasia
in the bone marrow of the ligamentous SIJ compartment
showed the same lesion also in the cartilaginous compart-
ment. However, concomitant BME in the cartilaginous
and ligamentous compartments was observed more fre-
quently in nr-axSpA than in NSBP patients (sensitivity/
specificity 0.42/0.98 and 0.12/0.98 for cohorts A and B, re-
spectively), which may assist towards discrimination of the
two conditions (Figs. 1 and 2).
Lesions in the ligamentous SIJ compartment were more
frequently reported in AS than in nr-axSpA patients. This
observation is in agreement with the findings of an earlier
retrospective study, which reported BME in enthesial SIJ
structures more commonly in AS (40–86 %) than in pa-
tients with early undifferentiated SpA (26–43 %) [10]. A
study recruiting 37 patients who fulfilled the ESSG criteria
showed a statistically significant association of liga-
mentous SIJ inflammation with AS according to the
Table 4 Impact of assessment of the ligamentous sacroiliac joint compartments on diagnosis of SpA versus nonSpA (mean percentage
of subjects over five readers)
Cohort A (n=89) B (n=88)
Group nr-axSpA AS NSBP HC nr-axSpA AS NSBP
Number of subjects 20 10 39 20 31 24 33
Lig essential for diagnosis of SpA vs Non-SpA 0 0 0 0 0.6c 0 0
Lig contributory for diagnosis of SpA vs Non-SpA 28.0 64.0 2.1 1.0 7.7 26.7 0
Lig non-contributory for diagnosis of SpA vs Non-SpA 72.0 36.0 97.9 99.0 91.6 73.3 100
Lig inducing change in diagnosisa 0 0 0 0 0 0 0
Lig inducing increase in confidence in diagnosisb 0 0 0 0 0.6c 0 0
aChange in diagnosis: assessment of the cartilaginous compartment alone indicating nonSpA (confidence 0–5) changed to SpA (confidence 5–10) by additional
evaluation of the ligamentous compartment
bIncrease in confidence of diagnosis: confidence in diagnosis of SpA increased from 5–7 to 8–10 following additional evaluation of the ligamentous compartment
cOne nr-axSpA patient by one reader in cohort B
AS Ankylosing spondylitis, HC Healthy control, Lig Ligamentous compartment of the sacroiliac joint, nr-axSpA Nonradiographic axial spondyloarthritis, NSBP Nonspecific
back pain, SpA Spondyloarthritis
Weber et al. Arthritis Research & Therapy  (2015) 17:246 Page 7 of 9modified New York criteria [21]. These earlier data sug-
gested that inflammation in the ligamentous SIJ compart-
ment may be indicative of longstanding rather than early
disease. However, our findings question this hypothesis as
we observed a comparable difference in lesion frequency
between nr-axSpA and AS groups also in the cartilaginous
compartment suggesting an overall accumulation of in-
flammatory lesions in both compartments over time. Only
a follow-up study assessing both SIJ compartments longi-
tudinally has the potential to clarify this issue.
Agreement for BME was substantial both in the cartil-
aginous and ligamentous compartment (kappa for five
readers jointly 0.66 and 0.68, respectively) in cohort A. In
cohort B, agreement was substantial in the cartilaginousFig. 2 Thirty-one-year-old woman with remitting mechanical back pain over
compartment demonstrates increased signal intensity compatible with bone
visible on the transitional slice nor in the ligamentous compartment. See lege
inversion recovery, T1SE T1 spin echocompartment (kappa 0.64) and fair in the ligamentous
compartment (kappa 0.37), the latter finding possibly at-
tributable to a much lower frequency of ligamentous BME
lesions compared to cohort A. A Dutch study on SIJ MRI
in 68 patients with inflammatory back pain, but lacking a
control group, showed comparable agreement on BME in
the cartilaginous compartment (kappa for two readers for
right/left SIJ 0.73/0.65), but a lower agreement in the liga-
mentous compartment (kappa for right/left SIJ 0.49/0.38)
[38]. In our study, agreement for fat metaplasia in both
joint compartments was lower than for BME.
An additional assessment of the ligamentous SIJ com-
partment provided no incremental value for diagnosis of
axial SpA nor for confidence with this diagnosis overseveral years. The sacral part of the left sacroiliac joint in the cartilaginous
marrow edema (curved white and black arrows on STIR), which is not
nd to Fig. 1 for details on the structure of the figure. STIR short tau
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cartilaginous compartment of the SIJ is evaluated. This
finding is most likely due to a nearly complete redun-
dancy between ligamentous and cartilaginous SIJ MRI
lesions. There was virtually no isolated inflammation in
the ligamentous SIJ compartment alone without associ-
ated lesions in the cartilaginous compartment. This ob-
servation is in line with the results of a previous report
in which only 1 of 37 patients fulfilling the ESSG criteria
showed isolated inflammation of just the ligamentous
SIJ compartment [21]. However, in our study, concomi-
tant BME lesions both in the cartilaginous and ligament-
ous compartment showed more frequently in nr-axSpA
(12–42 %) than in NSBP patients (2 %). If confirmed by
other studies, this MRI feature may facilitate the clinic-
ally often challenging discrimination between the two
conditions.
A study limitation shared with most other evalu-
ation modules of SIJ MRI is the lack of additional
semi-axial slices, as proposed by the Danish working
group [3, 20–22, 39]. Semi-axial slices running per-
pendicularly to the long axis of the SIJ, in contrast to the
traditional semi-coronal imaging of the SIJ, may permit a
more precise anatomical localization of MRI lesions by
simultaneous visualization of both compartments and
their anatomical border on the same image [3, 20]. Both
sequences viewed together facilitate the identification of
normal MRI features and variants that may mimic SpA-
associated inflammatory SIJ lesions on the semi-coronal
plane alone [3], such as normal vascular structures mim-
icking BME or the normal variant of a bipartite ilium
suggesting erosion by semi-coronal slices only [2]. An
additional semi-axial plane may also help to recognize
partial volume artifacts between the cartilaginous and the
ligamentous compartment, which may be misinterpreted
as erosion on semi-coronal images alone [40].
However, data are lacking whether additional semi-
axial slices facilitate evaluation of the ligamentous com-
partment leading to enhanced diagnostic utility of SIJ
MRI in nr-axSpA. Two of our findings, that question a
potentially relevant role of additional semi-axial slices,
are the low frequency of ligamentous SIJ inflammation
in early disease, and the very high association of inflam-
matory features in both compartments. Another challenge
is the technically difficult assessment of the ligamentous
compartment. Its irregular contour prevents a quadrant-
based evaluation similar to the cartilaginous compart-
ment, and defining a reproducible demarcation where the
ligamentous compartment ends posteriorly is challenging.
Conclusion
Assessment of MRI bone marrow lesions in the liga-
mentous SIJ compartment provided no incremental
value towards diagnosis of nr-axSpA. Moreover, it didnot enhance confidence in the diagnosis over and above
the traditional evaluation of the cartilaginous compart-
ment alone, when using semi-coronal images. The most
likely explanation was a high level of redundancy with
MRI BME and fat metaplasia lesions occurring concomi-
tantly in the ligamentous and cartilaginous compart-
ments. However, BME observed simultaneously in both
SIJ compartments might facilitate the clinically relevant
discrimination between nr-axSpA and NSBP patients be-
cause the latter showed concomitant inflammation in
both compartments only very rarely.
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